Quantcast

Paragon acquisition gives a jolt to Md. biotech industry

Ten years ago, Paragon Bioservices moved into the University of Maryland BioPark with just 30 employees and a change of direction to focus on manufacturing gene therapies. Monday the firm announced that it had agreed to be acquired by Catalent Biologics in a more than $1.2 billion deal expected to be completed this quarter. It has ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*